Variation within the glycoprotein B gene of human cytomegalovirus is due to homologous recombination

Journal of General Virology

Volumn 80, Issue 6, 1999, Pages 1495-1500

  Haberland, Michael ^a   Meyer König, Ursula ^a   Hufert, Frank T ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL ARTICLE; DNA SEQUENCE; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; LEUKOCYTE; MOLECULAR CLONING; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; VIRUS GENE; VIRUS RECOMBINATION;

DNA VIRUSES; HUMAN HERPESVIRUS 5;

EID: 0344417055     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-80-6-1495     Document Type: Article

References (29)

1. Basgoz, N., Qadri, I., Navarro, D., Sears, A., Lennette, E., Youngblom, J. & Pereira, P. (1992). The amino terminus of human cytomegalovirus glycoprotein B contains epitopes that vary among strains. Journal of General Virology 73, 983-988.
2. Benson, J. D. & Huang, E. S. (1990). Human cytomegalovirus induces expression of cellular topoisomerase II. Journal of Virology 64, 9-15.
3. Bongarts, A., von Laer, D., Vogelberg, Ch., Ebert, K., van Lunzen, J., Garweg, J., Veith, P., Hufert, F. T., Haller, O. & Meyer-König, U. (1996). Glycoprotein B genotype of human cytomegalovirus: distribution in HIV infected patients. Scandinavian Journal of Infectious Diseases 28, 447-449.
4. Britt, W. J. & Mach, M. (1996). Human cytomegalovirus glycoproteins. [Review: 97 refs] Intervirology 39, 401-412.
5. Britt, W. J., Vugler, L., Butfiloski, E. J. & Stephens, E. B. (199O). Cell surface expression of human cytomegalovirus (HCMV) gp55-116 (gB): use of HCMV-recombinant vaccinia virus-infected cells in analysis of the human neutralizing antibody response. Journal of Virology 64,1079-1085.
6. Chou, S.W. (1989). Reactivation and recombination of multiple cytomegalovirus strains from individual organ donors. Journal of Infectious Diseases 160, 11-15.
7. Chou, S. (1992). Comparative analysis of sequence variation in gp116 and gp55 components of glycoprotein B of human cytomegalovirus. Virology 188, 388-390.
8. Chou,S. W. & Dennison, K. M. (1991). Analysis of interstrain variation in cytomegalovirus glycoprotein B sequences encoding neutralization-related epitopes. Journal of Infectious Diseases 163, 1229-1234.
9. Farrell, H. E., Vally, H., Lynch, D. M., Fleming, P., Shellam, G. R. & Scalzo, A. A. D. P. (1997). Inhibition of natural killer cells by a cytomegalovirus MHC class I homologue in vivo [see comments]. Nature 386, 510-514.
10. Fries, B. C., Chou, S., Boeckh, M. & Torok Storb, B. (1994). Frequency distribution of cytomegalovirus envelope glycoprotein genotypes in bone marrow transplant recipients. Journal of Infectious Diseases 169, 769-774.
11. Hengel, H., Flohr, T., Hämmerling, G. J., Koszinowski, U. H. & Momburg, F. (1996). Human cytomegalovirus inhibits peptide translocation into the endoplasmic reticulum for MHC class I assembly. Journal of General Virology 77, 2287-2296.
12. Lingen, M., Hengerer, F. & Falke, D. (1997). Mixed vaginal infections of Balb/c mice with low virulent herpes simplex type 1 strains result in restoration of virulence properties: vaginitis/vulvitis and neuroinvasiveness. Medical Microbiology & Immunology 185, 217-222.
13. Meyer, H., Sundqvist, V.-A., Pereira, L. & Mach, M. (1992). Glycoprotein gp116 of human cytomegalovirus contains epitopes for strain-common and strain-specific antibodies. Journal of General Virology 73, 2375-2383.
14. Meyerhans, A., Vartanian, J. P. & Wain Hobson, S. (1990). DNA recombination during PCR. Nucleic Acids Research 18, 1687-1691.
15. Meyer-König, U., Serr, A., Hufert, F. T., Strik, M., Kirste, G., Haller, O. & Neumann-Haefelin, D. (1995). Laboratory diagnosis of HCMV-related disease in renal transplant patients - pp65 antigen detection versus nested PCR. Clinical Diagnostic Virology 3, 49-59.
16. Meyer-König, U., Haberland, M., von Laer, D., Haller, O. & Hufert, F. T. (1998a). Intragenic variability of human cytomegalovirus glycoprotein B in clinical strains. Journal of Infectious Diseases 177, 1162-1169.
17. Meyer-König, U., Schrage, B., Huzly, D., Bongarts, A. & Hufert, F. T. (1998b). High variability of cytomegalovirus glycoprotein B gene and frequent multiple infections in HIV-infected patients with low CD4 T-cell count. AIDS 12, 2228-2230.
18. Meyer-König, U., Vogelberg, C., Bongarts, A., Kampa, D., Delbrück, R., Wolff-Vorbeck, G., Kirste, G., Haberland, M., Hufert, F. T. & von Laer, D. (1998c). Glycoprotein B genotype correlates with cell tropism in vivo of human cytomegalovirus infection. Journal of Medical Virology 55, 75-81.
19. Navarro, D., Paz, P., Tugizov, S., Topp, K., La Vail, J. & Pereira, L. (1993). Glycoprotein B of human cytomegalovirus promotes virion penetration into cells, transmission of infection from cell to cell, and fusion of infected cells. Virology 197, 143-158.
20. Rasmussen, L., Hong, C., Zipeto, D., Morris, S., Sherman, D., Chou, S. & Miner, R. (1997). Cytomegalovirus gB genotype distribution differs in human immunodeficiency virus-infected patients and immunocompromised allograft recipients. Journal of Infectious Diseases 175, 179-184.
21. Roy, D. M., Grundy, J. E. & Emery, V. C. (1993). Sequence variation within neutralizing epitopes of the envelope glycoprotein B of human cytomegalovirus: comparison of isolates from renal transplant recipients and AIDS patients, Journal of General Virology 74, 2499-2505.
22. Schreiber, M., Mueller, H., Wachsmuth, Ch., Laue, T., Hufert, F. T., von Laer, D. & Schmitz, H. (1997). Escape of HIV-1 is associated with lack of V3 domain specific antibodies in vivo. Clinical and Experimental Immunology 107, 15-20.
23. Spaete, R. R., Thayer, R. M., Probert, W. S., Masiarz, F. R., Chamberlain, S. H. R., Merigan, T. C. & Pachl, C. (1988). Human cytomegalovirus strain Towne glycoprotein B is processed by proteolytic cleavage. Virology 167, 207-225.
24. Utz, U., Britt, W., Vugler, L. & Mach, M. (1989). Identification of a neutralizing epitope on glycoprotein gp58 of human cytomegalovirus. Journal of Virology 63, 1995-2001.
25. Vogelberg, Ch., Meyer-König, U., Hufert, F. T., Kirste, G. & von Laer, D. (1996). Human cytomegalovirus glycoprotein B genotypes in renal transplant recipients. Journal of Medical Virology 50, 31-34.
26. Walling, D. M. & Raab-Traub, N. (1994). Epstein-Barr virus intrastrain recombination in oral hairy leukoplakia. Journal of Virology 68, 7909-7917.
27. Walling, D. M., Perkins, A. G., Webster-Cyriaque, J., Resnick, L. & Raab-Traub, N. (1994). The Epstein-Barr virus EBNA-2 gene in oral hairy leukoplakia: strain variation, genetic recombination, and transcriptional expression. Journal of Virology 68, 7918-7926.
28. Wiertz, E. J., Jones, T. R., Sun, L., Bogyo, M., Geuze, H. J. & Ploegh, H. L. (1996a). The human cytomegalovirus USlI gene product dislocates MHC class I heavy chains from the endoplasmic reticulum to the cytosol. Cell 84, 769-779.
29. Wiertz, E. J., Tortorella, D., Bogyo, M., Yu, J., Mothes, W., Jones, T. R., Rapoport, T. A. & Ploegh, H. L. (1996b). Sec61-mediated transfer of a membrane protein from the endoplasmic reticulum to the proteasome for destruction [see comments]. Nature 384, 432-438.